Series D Funded Startups in Israel
Among the 26 most recent Israel Series D rounds shown (sorted by date descending), AI21 Labs’ $300M on 2025-05-11 stands out as an outlier: it sits well ab…
Among the 26 most recent Israel Series D rounds shown (sorted by date descending), AI21 Labs’ $300M on 2025-05-11 stands out as an outlier: it sits well above the next-highest disclosed rounds (e.g., Silverfort at $116M on 2024-01-23 and UVeye at $100M on 2023-05-09), making it the only entry in this set in the $300M range. The rest of the disclosed amounts concentrate mostly between $40M and $161M, with a narrower cluster around the $50M–$116M band (for example: proteanTecs $51M on 2025-09-14; Beewise $50M on 2025-06-09; Scopio Labs $10M is the low-end case at the other extreme).
Sector and geography both show concentration: Artificial Intelligence (AI) appears in 8 of 26 entries (AI21 Labs 2025-05-11; Scopio Labs 2025-07-24; Cortica 2023-10-03; UVeye 2023-05-09; Pliops 2022-08-16; Aidoc 2022-06-16; Optibus 2022-05-16; WSC Sports 2022-02-15), while Tel Aviv (including Tel Aviv-Yafo and Tel Aviv city listings) is the dominant city pattern across multiple rounds (e.g., Scopio Labs in Tel Aviv, Silverfort in Tel Aviv, UVeye in Tel Aviv-Yafo, and Optibus in Tel Aviv). Temporally, the visible window runs from 2021-04-07 (WhiteSource) to 2025-09-14 (proteanTecs), with the most recent burst largely landing in 2025 (10 of 26 entries are dated 2025).
Most recent rounds
26 shownRelated listings
Frequently asked
What’s the largest disclosed Series D round in this Israel list, and how unusual is it versus the rest?
AI21 Labs’ $300M (2025-05-11) is the clear high outlier in the disclosed amounts. The next tier is materially lower, such as Silverfort at $116M (2024-01-23) and UVeye and multiple others at $100M (e.g., UVeye 2023-05-09; several $100M rounds in 2022), so $300M dwarfs the rest of the table’s disclosed maxima.
Which companies anchor the low end, and where does the smallest disclosed amount sit relative to the overall range?
Scopio Labs is the smallest disclosed round at $10M (2025-07-24). That makes the distribution notably spread: the same table includes higher disclosed entries like Pixellot $161M (2022-06-13) and Hibob $150M (2022-08-17), with most values clustered well above $10M.
Do the rounds cluster in a narrow time window near the latest dates?
Yes, the most recent period is dense: 10 of 26 entries are dated in 2025, including proteanTecs $51M (2025-09-14), Scopio Labs $10M (2025-07-24), and Beewise $50M (2025-06-09). The table’s date span runs from 2021-04-07 (WhiteSource) through 2025-09-14 (proteanTecs), indicating a heavy skew toward the latest year.
Are any sectors over-represented among these Israel Series D rounds?
Artificial Intelligence (AI) is the most frequent sector, appearing in 8 of the 26 rows (e.g., AI21 Labs 2025-05-11 at $300M; Cortica 2023-10-03 at $40M; Aidoc 2022-06-16 at $110M; Optibus 2022-05-16 at $100M). The AI concentration is higher than other repeated categories such as Agriculture and Farming (3 entries: Beewise 2025-06-09, Equinom 2022-12-12, and StoreDot is Energy rather than ag).
Is there a city-level hub pattern, or do companies distribute broadly across locations?
Tel Aviv-related locations dominate the listings, with multiple entries explicitly based in Tel Aviv or Tel Aviv-Yafo (e.g., Silverfort in Tel Aviv on 2024-01-23 at $116M; UVeye in Tel Aviv-yafo on 2023-05-09 at $100M; Optibus in Tel Aviv on 2022-05-16 at $100M; and Gauzy in Tel Aviv-yafo on 2022-02-08 at $60M). Other cities do appear (Jerusalem for Lightricks 2021-09-19 at $100M; Haifa for proteanTecs 2025-09-14 at $51M), but the strongest repeat pattern is Tel Aviv.
Any outliers beyond company size that might affect how these deals are interpreted for outreach or underwriting?
Besides AI21 Labs’ $300M outlier, the mix includes a sharp low-end counterpoint in Scopio Labs’ $10M (2025-07-24) within the same Series D cohort. Sector-wise, the AI-heavy set includes non-AI categories as well, such as Hibob in Administrative Services at $150M (2022-08-17) and ThetaRay in Financial Services at $57M (2023-09-05), which can signal different unit economics and risk profiles even when the stage is consistent.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.